Cinqair
Cinqair is a prescription medicine used to treat the symptoms of Asthma. Cinqair may be used alone or with other medications.
Cinqair belongs to a class of drugs called Interleukin Inhibitors; Monoclonal Antibodies, Anti-asthmatics.
CINQAIR (reslizumab) is a humanized interleukin-5 antagonist monoclonal antibody (IgG4κ). Reslizumab is produced by recombinant DNA technology in murine myeloma non-secreting 0 (NS0) cells. Reslizumab has a molecular weight of approximately 147 kDa.
Cinqair Info
CINQAIR is for intravenous infusion only. Do not administer as an intravenous push or bolus.
The recommended dosage regimen is 3 mg/kg once every 4 weeks administered by intravenous infusion over 20-50minutes.
Cinqair Side Effects
The most common side effects include:
- sore throat, and
- muscle pain
Patient Assistance Programs
There are several programs patients can sign up for that will assist in treatment costs:
Resources
To learn more about this treatment, browse the resources below.
Ready to get started?
Contact us to chat with one of our helpful scheduling specialists!